ONWARD Medical Receives FDA IDE Approval to Initiate the Empower BP Pivotal Study with the ARC-IM System GlobeNewswire August 18, 2025 THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014) The investigational device exemption (IDE) allows initiation of a global pivotal study designed to assess […]
(NYSE:SOC), SAN FRANCISCO, Aug. 18, 2025 (GLOBE NEWSWIRE) — Sable Offshore Corp. (NYSE: SOC) is now at the center of a securities class-action lawsuit, alleging that the company misled investors to inflate its stock price just before a major secondary offering. The drama unfolded around the company's long-delayed efforts to restart operations at its San
SAN FRANCISCO, Aug. 18, 2025 (GLOBE NEWSWIRE) — On August 4, 2025, the court overseeing the pending securities class action styled Christiansen v. Spectrum Pharmaceuticals, Inc., et al., No. 1:22-cv-10292 (S.D.N.Y.) re-opened the lead plaintiff process and set September 24, 2025 as the deadline for investors to seek appointment as the new lead plaintiff. The
Sable Offshore Corp. (SOC) Hit with Lawsuit Over Alleged Misleading Statements on California Oil Restart – Hagens Berman SOC Investors with Losses Encouraged to Contact Hagens Berman GlobeNewswire August 18, 2025 SAN FRANCISCO, Aug. 18, 2025 (GLOBE NEWSWIRE) — Sable Offshore Corp. (NYSE: SOC) is now at the center of a securities class-action lawsuit, alleging
Spectrum Pharmaceuticals (SPPI) Lead Plaintiff Process Re-Opened, Investors with Losses Urged to Contact Hagens Berman Before September 24, 2025 Deadline GlobeNewswire August 18, 2025 SAN FRANCISCO, Aug. 18, 2025 (GLOBE NEWSWIRE) — On August 4, 2025, the court overseeing the pending securities class action styled Christiansen v. Spectrum Pharmaceuticals, Inc., et al., No. 1:22-cv-10292 (S.D.N.Y.)
NEW YORK, NY / ACCESS Newswire / August 18, 2025 / If you suffered a loss on your Hims & Hers Health, Inc. (NYSE:HIMS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/hims-hers-health-inc-lawsuit-submission-form?prid=162148&wire=1&utm_campaign=30 or contact Joseph E. Levi, Esq. via email at
NEW YORK, NY / ACCESS Newswire / August 18, 2025 / If you suffered a loss on your Centene Corporation (NYSE:CNC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/centene-corporation-lawsuit-submission-form?prid=162147&wire=1&utm_campaign=14 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call
NEW YORK, NY / ACCESS Newswire / August 18, 2025 / If you suffered a loss on your Flywire Corporation (NASDAQ:FLYW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/flywire-corporation-lawsuit-submission-form?prid=162146&wire=1&utm_campaign=27 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call
NEW YORK, Aug. 18, 2025 (GLOBE NEWSWIRE) — TalkMe AI, the flagship product of Singapore-based Inspired AI, turned heads at Google I/O with a fully AI-generated brand film built on Google's Gemini, Veo 3, and Flow models. The short tells the story of a penguin learning English under the mantra “Don't worry. Give it a
TalkMe Brings a Penguin to Life at Google I/O, Redefining AI Language Learning AI-native app showcases storytelling power and user stickiness with 1M+ learners GlobeNewswire August 18, 2025 NEW YORK, Aug. 18, 2025 (GLOBE NEWSWIRE) — TalkMe AI, the flagship product of Singapore-based Inspired AI, turned heads at Google I/O with a fully AI-generated brand